Securing US FCC certification has enabled Elsight to enter a strategic partnership with Kinetx Prime to deliver direct-to-consumer telehealth services in the US with its flagship “Halo” product.
Elsight has received an initial order of USD$1.6M (A$2.3 million) with the prospect of material repeat orders up to the size of the initial order, over the course of the next 36 months.
Elsight has entered a new and substantial market driven by the twin issues of the increase in the COVID-19 pandemic in America and limited access to normal healthcare services in underserved communities where availability of local hospital services are limited and far away, starting with hundreds of rural medical facilities.
Kinetx Prime, LLC, based in Alpharetta, GA, USA, focuses on the application of technology solutions using private and public cellular networks to enhance the connectively of rural communities and urban commercial applications. Leveraging the innovative design and fabrication approaches of Qube-MRS, LLC, Kinetx Prime offers infrastructure solutions and services to bridge the digital divide in underserved communities.
This represents the first time that Halo will be mass distributed in the business-to-consumers (B-to-C) market in North America.
After a substantial regimen of trials and certification processes, Halo proof-of-concept (POC) projects are expected to be much shorter driving new deals with material revenues during the remaining of 2020 and beyond.
- Forums
- ASX - By Stock
- ELS
- Ann: Largest HALO order to date with US customer
ELS
elsight limited
Add to My Watchlist
3.85%
!
$1.63

Ann: Largest HALO order to date with US customer, page-2
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.63 |
Change
-0.065(3.85%) |
Mkt cap ! $295.3M |
Open | High | Low | Value | Volume |
$1.70 | $1.77 | $1.59 | $1.165M | 699.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4591 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 6000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4591 | 1.625 |
1 | 2500 | 1.610 |
1 | 1400 | 1.595 |
3 | 60041 | 1.590 |
1 | 50000 | 1.585 |
Price($) | Vol. | No. |
---|---|---|
1.655 | 6000 | 1 |
1.700 | 15500 | 2 |
1.750 | 18000 | 2 |
1.755 | 14787 | 1 |
1.765 | 17929 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
ELS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online